Wearable Wireless Respiratory Monitoring System That Detects and Predicts Opioid Induced Respiratory Depression

NCT ID: NCT06442488

Last Updated: 2025-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

14 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-01

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An observational study will be conducted in approximately 14 participants to evaluate the ability of a wearable, wireless acoustic Respiratory Monitoring System (RMS) to accurately measure a participant's respiratory rate, tidal volume, minute ventilation, and duration of apnea in a noisy environment. Sensor accuracy will be measured with adaptive filtering and active noise cancellation turned on versus turned off.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Respiratory Monitoring System (RMS) consists of a miniature acoustic sensor and a soft flexible cradle that is adhered to the skin of the neck over the proximal trachea (within the sternal notch) with medical grade adhesive. The sensor body consists of a miniature bell stethoscope head, electronics, a microphone that faces the trachea and a microphone that faces the external environment, a Bluetooth low energy transmitter/receiver, an antenna, and a rechargeable battery. The sensor is secured by the cradle at the optimal location to measures the sounds of airflow in the proximal trachea during inhalation and exhalation.

Proprietary machine learning/AI algorithms convert the sounds of airflow into the measurements of respiratory rate (RR), tidal volume (TV), minute ventilation (MV), and duration of apnea. Sensor information is transmitted to a bedside PC that displays the vital sign data in real-time. The wearable, wireless RMS is being developed for hospital and outpatient use as a tool to detect and predict respiratory compromise/clinical deterioration in a more-timely and accurately manor (fewer false alerts/alarms) than current methods.

The breathing data from 14 to 20 participants will be recorded during one study session lasting approximately 90 minutes with the sensor/cradle adhered to the neck over the proximal trachea. Reference breathing data will be recorded simultaneously using a hospital ventilator's pneumotach and capnometer attached to a tight-fitting face mask.

Each subject will be instructed to breath the following protocol 3 or 4 times:

Record RMS data and pneumotach/capnometer data for \~400 seconds with the study subject breathing a normal RR and TV.

Record RMS data and pneumotach/capnometer data for \~70 seconds with the study subject breathing a normal RR and an increased TV.

Record RMS data and pneumotach/capnometer data for \~70 seconds with the study subject breathing a normal RR and decreased TV.

Record RMS data and pneumotach/capnometer data for \~120 seconds with the study subject breathing a normal RR and normal TV with a period of apnea in the middle (15 seconds).

Record RMS data and pneumotach/capnometer data for \~120 seconds with the study subject breathing a normal RR and decreased TV, with a period of apnea in the middle (15 seconds).

Record RMS data and pneumotach/capnometer data for \~120 seconds with the study subject breathing a decreased RR and decrease TV with a period of apnea in the middle (15 seconds).

RMS data will be compared to reference pneumotach/capnometer data (RR, TV, MV, and duration of apnea) to determine the accuracy of measurement. Data will be recorded in an environment with simulated hospital noise with adaptive filtering and active noise cancellation turned on and turned off.

This observational human study will compare the signal-to-noise ratio (SNR) and the measurement accuracy of the RMS in a noisy environment with the adaptive filtering and active noise cancellation turned on versus turned off.

Participants will be contacted by telephone 3 to 4 days later to confirm no adverse effects from the study methods or wearing the sensor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Insufficiency Clinical Deterioration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Respiratory Monitoring System

Comparing the SNR and accuracy of measurement (RR, TV, MV, apnea duration) in a noisy external environment when the RMS has adaptive filtering and active noise cancellation turned on versus turned off.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 18 to 70 years.
2. BMI 20 to 38.
3. Subject understands the English language, understands the risks, benefits, and alternatives to this research study, and is willing and able to give written informed consent.

Exclusion Criteria

1. Age \<18 years\>70.
2. BMI \< 20 or \> 38.
3. Does not understand written and spoken English.
4. Anxiety or claustrophobia related to wearing a face mask.
5. History of skin irritation or inflammation related to the adhesive, adhesive tape, or materials used in the trachea sound sensor or facemask.
6. Active infection or inflammation of the skin above the proximal trachea.
7. Excessive facial hair that may prevent a tight seal around the facemask.
8. Unstable cardiac, vascular, pulmonary, hepatic, renal, immune function at the discretion of the investigator.
9. Pregnancy or breast feeding.
10. Current participation in an industry sponsored pharmaceutical study or a medical device study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

RTM Vital Signs, LLC

INDUSTRY

Sponsor Role collaborator

Jeffrey Joseph

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jeffrey Joseph

Professor of Anesthesiology

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Yu L, Ting CK, Hill BE, Orr JA, Brewer LM, Johnson KB, Egan TD, Westenskow DR. Using the entropy of tracheal sounds to detect apnea during sedation in healthy nonobese volunteers. Anesthesiology. 2013 Jun;118(6):1341-9. doi: 10.1097/ALN.0b013e318289bb30.

Reference Type BACKGROUND
PMID: 23407106 (View on PubMed)

Chen G, de la Cruz I, Rodriguez-Villegas E. Automatic lung tidal volumes estimation from tracheal sounds. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:1497-500. doi: 10.1109/EMBC.2014.6943885.

Reference Type BACKGROUND
PMID: 25570253 (View on PubMed)

Thakor NV, Zhu YS. Applications of adaptive filtering to ECG analysis: noise cancellation and arrhythmia detection. IEEE Trans Biomed Eng. 1991 Aug;38(8):785-94. doi: 10.1109/10.83591.

Reference Type BACKGROUND
PMID: 1937512 (View on PubMed)

Ramsay MA, Usman M, Lagow E, Mendoza M, Untalan E, De Vol E. The accuracy, precision and reliability of measuring ventilatory rate and detecting ventilatory pause by rainbow acoustic monitoring and capnometry. Anesth Analg. 2013 Jul;117(1):69-75. doi: 10.1213/ANE.0b013e318290c798. Epub 2013 Apr 30.

Reference Type BACKGROUND
PMID: 23632055 (View on PubMed)

Harper VP, Pasterkamp H, Kiyokawa H, Wodicka GR. Modeling and measurement of flow effects on tracheal sounds. IEEE Trans Biomed Eng. 2003 Jan;50(1):1-10. doi: 10.1109/TBME.2002.807327.

Reference Type BACKGROUND
PMID: 12617519 (View on PubMed)

Patino M, Kalin M, Griffin A, Minhajuddin A, Ding L, Williams T, Ishman S, Mahmoud M, Kurth CD, Szmuk P. Comparison of Postoperative Respiratory Monitoring by Acoustic and Transthoracic Impedance Technologies in Pediatric Patients at Risk of Respiratory Depression. Anesth Analg. 2017 Jun;124(6):1937-1942. doi: 10.1213/ANE.0000000000002062.

Reference Type BACKGROUND
PMID: 28448390 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R44DA059491-01

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.